BioWorld-International-2002-02-13
NeuroSearch, Ingelheim Enter $80M Alliance Around NS2330
NeuroSearch, Ingelheim Enter $80M Alliance Around NS2330
Shares in NeuroSearch A/S surged more than 50 percent Friday on news of its largest ever deal, a US$80 million pact with Boehringer Ingelheim GmbH to develop its candidate Alzheimers and Parkinsons drug, NS2330. (BioWorld International)

